GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » 3-Year EBITDA Growth Rate

Thyrocare Technologies (NSE:THYROCARE) 3-Year EBITDA Growth Rate : -7.20% (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies 3-Year EBITDA Growth Rate?

Thyrocare Technologies's EBITDA per Share for the three months ended in Dec. 2024 was ₹8.49.

During the past 12 months, Thyrocare Technologies's average EBITDA Per Share Growth Rate was 30.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -7.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Thyrocare Technologies was 26.90% per year. The lowest was -9.40% per year. And the median was 17.40% per year.


Competitive Comparison of Thyrocare Technologies's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Thyrocare Technologies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thyrocare Technologies's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's 3-Year EBITDA Growth Rate falls into.


;
;

Thyrocare Technologies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Thyrocare Technologies  (NSE:THYROCARE) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Thyrocare Technologies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Thyrocare Technologies Business Description

Traded in Other Exchanges
Address
D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies Headlines

No Headlines